Innate immune signalling, neuroinflammation and network plasticity in temporal lobe epilepsy

Area of Science:

• Neuroscience
• Immunology
• Epilepsy Research

Background:

• Temporal lobe epilepsy (TLE) arises from brain insults causing hippocampal changes and seizures.
• Innate immune pathways are central drivers of epileptogenesis, not just secondary effects.

Purpose of the Study:

• To elucidate the role of innate immunity in TLE pathogenesis.
• To identify potential therapeutic targets within immune pathways for TLE treatment.

Main Methods:

• Analysis of chemoconvulsant models, viral encephalitis paradigms, and human epilepsy tissue.
• Investigation of pattern-recognition receptors (e.g., TLRs, NLRP3 inflammasome) and downstream signaling.
• Evaluation of targeted immunomodulatory interventions.

Main Results:

• Innate immune activation amplifies inflammation, alters neuronal excitability, and impairs inhibition, lowering seizure threshold.
• Sustained immune activation promotes microglial polarization, synaptic loss, and circuit hyperexcitability.
• Targeted inhibitors of TLR4, IL-1, and NLRP3 reduced seizure burden and hippocampal damage.

Conclusions:

• Innate immunity is a key, targetable mechanism in TLE.
• Immunomodulatory therapies, combined with existing treatments, show promise for disease modification and treating drug-resistant epilepsy.